PortfoliosLab logo
Insulet Corporation (PODD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45784P1012

CUSIP

45784P101

IPO Date

May 15, 2007

Highlights

Market Cap

$18.31B

EPS (TTM)

$5.79

PE Ratio

45.03

PEG Ratio

6.62

Total Revenue (TTM)

$1.46B

Gross Profit (TTM)

$1.14B

EBITDA (TTM)

$339.30M

Year Range

$160.19 - $289.46

Target Price

$312.27

Short %

4.47%

Short Ratio

2.70

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Insulet Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


500.00%1,000.00%1,500.00%NovemberDecember2025FebruaryMarchApril
1,533.52%
268.06%
PODD (Insulet Corporation)
Benchmark (^GSPC)

Returns By Period

Insulet Corporation had a return of -0.14% year-to-date (YTD) and 56.87% in the last 12 months. Over the past 10 years, Insulet Corporation had an annualized return of 24.29%, outperforming the S&P 500 benchmark which had an annualized return of 10.27%.


PODD

YTD

-0.14%

1M

0.76%

6M

11.59%

1Y

56.87%

5Y*

6.37%

10Y*

24.29%

^GSPC (Benchmark)

YTD

-6.06%

1M

-1.00%

6M

-4.87%

1Y

8.34%

5Y*

14.11%

10Y*

10.27%

*Annualized

Monthly Returns

The table below presents the monthly returns of PODD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20256.63%-2.19%-3.55%-0.72%-0.14%
2024-12.03%-14.08%4.51%0.32%3.05%13.89%-3.69%4.33%14.79%-0.52%15.22%-2.14%20.32%
2023-2.40%-3.81%15.41%-0.29%-13.77%5.14%-4.02%-30.73%-16.81%-16.88%42.63%14.75%-26.30%
2022-6.79%6.73%0.64%-10.29%-10.67%2.09%13.70%3.10%-10.20%12.82%15.67%-1.66%10.64%
20214.52%-3.02%0.70%13.15%-8.65%1.79%1.89%6.48%-4.56%9.07%-6.96%-7.76%4.08%
202013.34%-2.10%-12.79%20.55%-5.58%3.02%4.68%7.32%8.40%-6.06%15.96%-0.81%49.32%
20192.36%15.67%1.26%-9.30%27.29%8.73%2.98%25.40%6.98%-11.89%27.79%-7.81%115.83%
201810.91%-1.88%15.43%-0.78%9.06%-8.63%-2.96%25.38%1.61%-16.74%-4.85%-5.49%14.96%
201710.40%4.71%-1.08%0.74%-3.32%22.25%-1.95%15.40%-5.13%6.77%21.97%-3.81%83.12%
2016-12.25%-7.66%8.22%0.42%-9.85%0.73%17.03%19.61%-3.28%-9.33%-9.35%11.98%-0.34%
2015-36.19%7.96%5.11%-10.49%-5.29%9.60%9.38%-12.33%-12.79%15.40%22.37%3.33%-17.91%
201415.90%10.26%0.02%-20.65%-2.66%8.30%-10.92%2.18%2.05%17.15%7.92%-1.14%24.15%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 89, PODD is among the top 11% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PODD is 8989
Overall Rank
The Sharpe Ratio Rank of PODD is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of PODD is 8787
Sortino Ratio Rank
The Omega Ratio Rank of PODD is 8787
Omega Ratio Rank
The Calmar Ratio Rank of PODD is 8686
Calmar Ratio Rank
The Martin Ratio Rank of PODD is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Insulet Corporation (PODD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for PODD, currently valued at 1.52, compared to the broader market-2.00-1.000.001.002.003.00
PODD: 1.52
^GSPC: 0.46
The chart of Sortino ratio for PODD, currently valued at 2.11, compared to the broader market-6.00-4.00-2.000.002.004.00
PODD: 2.11
^GSPC: 0.77
The chart of Omega ratio for PODD, currently valued at 1.28, compared to the broader market0.501.001.502.00
PODD: 1.28
^GSPC: 1.11
The chart of Calmar ratio for PODD, currently valued at 1.09, compared to the broader market0.001.002.003.004.005.00
PODD: 1.09
^GSPC: 0.47
The chart of Martin ratio for PODD, currently valued at 9.55, compared to the broader market-5.000.005.0010.0015.0020.00
PODD: 9.55
^GSPC: 1.94

The current Insulet Corporation Sharpe ratio is 1.52. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Insulet Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
1.52
0.46
PODD (Insulet Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Insulet Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-21.05%
-10.07%
PODD (Insulet Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Insulet Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Insulet Corporation was 90.28%, occurring on Mar 11, 2009. Recovery took 1046 trading sessions.

The current Insulet Corporation drawdown is 21.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.28%Dec 3, 2007320Mar 11, 20091046May 7, 20131366
-61.31%May 15, 2023105Oct 12, 2023
-50.82%Mar 21, 2014478Feb 11, 2016345Jun 26, 2017823
-41.44%Nov 10, 2021126May 11, 2022214Mar 20, 2023340
-39.93%Feb 21, 202019Mar 18, 202036May 8, 202055

Volatility

Volatility Chart

The current Insulet Corporation volatility is 14.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
14.96%
14.23%
PODD (Insulet Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Insulet Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Insulet Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
PODD: 45.0
The chart displays the Price-to-Earnings (P/E) ratio for PODD, comparing it with other companies in the Medical Devices industry. Currently, PODD has a P/E ratio of 45.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
PODD: 6.6
The chart shows the Price/Earnings to Growth (PEG) ratio for PODD compared to other companies in the Medical Devices industry. PODD currently has a PEG ratio of 6.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
2.04.06.08.010.0
PODD: 8.8
This chart shows the Price-to-Sales (P/S) ratio for PODD relative to other companies in the Medical Devices industry. Currently, PODD has a P/S ratio of 8.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
2.04.06.08.010.0
PODD: 15.1
The chart illustrates the Price-to-Book (P/B) ratio for PODD in comparison with other companies in the Medical Devices industry. Currently, PODD has a P/B value of 15.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items